Litcius/Paper detail

Systematic Evaluation of the Accelerate Pheno System for Susceptibility Testing of Gram-Negative Bacteria Isolated from Blood Cultures

Yera A. Patel, Thomas J. Kirn, Melvin P. Weinstein, Priyanka Uprety

2021Microbiology Spectrum14 citationsDOIOpen Access PDF

Abstract

This was an 8-month retrospective and prospective study looking at the analytical performance of the Accelerate Pheno system on clinical isolates obtained from patients seen in our tertiary care hospital. Most of the published literature on the analytical performance of Accelerate Pheno System has been from clinical trials with limited data from clinical microbiology laboratories postimplementation of the system. Here we compare the AST results on 355 blood cultures growing Gram-negative bacteria in Accelerate Pheno system with the CLSI reference disk diffusion (DD) method. The findings from this study highlight the "real-world" performance of the Accelerate Pheno system for Gram-negative bacteria from blood cultures. We provide data to show the reliable susceptibility testing results of Enterobacterales for most of the commonly used antimicrobial agents and significant limitation for susceptibility testing results of Pseudomonas aeruginosa on the Accelerate Pheno system.

Topics & Concepts

CeftazidimeMicrobiologyCefepimeMeropenemAztreonamAmikacinBlood cultureCefotaximeErtapenemBiologyTobramycinCeftriaxoneCephalosporinEnterobacterPiperacillinAntimicrobialBacteremiaAntibioticsCiprofloxacinMedicineTrimethoprimGentamicinCarbapenemKlebsiellaImipenemPenicillinPseudomonas aeruginosaKlebsiella pneumoniaeProteusKanamycinBacterial Identification and Susceptibility TestingNeonatal and Maternal InfectionsAntimicrobial Resistance in Staphylococcus